Category: Education & courses, Young Fellows

In episode 3 of AtheroTalk, we spoke with Prof. Nicola Ferri about his inspiring academic journey. Our conversation highlighted the profound impact of mentors in…

In this conversation with Prof. Katey Rayner, a Chief Scientific Officer at the University of Ottawa Heart Institute, we hear about her career journey, the…

Making positive lifestyle changes including adopting a heart-healthy diet, stopping smoking, weight management and regular exercise are essential for maintaining optimal LDL-cholesterol levels and for reducing the…

In our first episode, we’re thrilled to speak with Prof. Anne Tybjaerg-Hansen from Rigshospitalet, Copenhagen University Hospital, Denmark. With over 40 years of experience in…

Lipotoxicity – a pathogenic mechanism of cell and organ damage by Prof Jan Borén The role of lipids in cardiovascular disease is well established through…

Processed foods, and especially ultra-processed foods (UPFs), are gaining widespread media attention due to associations with negative health outcomes, as highlighted by numerous observational studies.…

New insights in the genetics of FH by Prof Mafalda Bourbon Mafalda Bourbon is a senior researcher at the National Institute of Health in Portugal…

There is still an ongoing debate about the role of dietary lipids in the context of ASCVD prevention although there are clear guidelines for dietary…

Atherosclerotic cardiovascular disease (ASCVD) remains to be the leading cause of mortality and disabilityworldwide. Atherosclerosis, the underlying cause of cardiovascular disease (CVD), begins early in…

Gene therapy in lipid metabolism and CVD by Prof Sekar Kathiresan Sekar Kathiresan is the Chief Executive Officer and founder of Verve Therapeutics, US. Previously,…